LIPOGEN LLC is a young biotech company that focuses on discovery and characterization of novel therapeutics for treatment of cancer and obesity. We believe that targeting cancer at the very root of its existence is the most successful and the least invasive treatment option. While most of the treatments are consisted of either dealing with consequences of already developed disease, Lipogen is working on both early detection, and early inhibition of cancer’s growth potential. Our team of experienced scientist and entrepreneurs are dedicated to completely characterize and commercialize novel drugs for cancer treatment. Decades of research experience and business development among the member of our team scientists will ensure that LIPOGEN LLC will successfully reach the milestones in their projects and commercialize the products. 

LIPOGEN LLC is a member of NJTC.

Subscribe to LIPOGEN - 立博美华基因科技有限责任公司 RSS